143 related articles for article (PubMed ID: 33405278)
1. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
[No Abstract] [Full Text] [Related]
2. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
[TBL] [Abstract][Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
Seiwell AP; Buckley K; Pettenati M; Grier DD
Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
[No Abstract] [Full Text] [Related]
4. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
[TBL] [Abstract][Full Text] [Related]
5. Disseminated blastic plasmacytoid dendritic cell neoplasm.
Loghavi S; Khoury JD
Blood; 2015 Jul; 126(4):558. PubMed ID: 26421330
[No Abstract] [Full Text] [Related]
6. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
7. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm].
Saika W; Kawahara M; Tashiro H; Teramoto Y; Nagai S; Kumode M; Iwasa M; Asai A; Fujishiro A; Nishimura R; Minamiguchi H; Moritani S; Kito K; Andoh A
Rinsho Ketsueki; 2020; 61(12):1647-1653. PubMed ID: 33441515
[TBL] [Abstract][Full Text] [Related]
10. Sequential B-lymphoid and myeloid blastic transformation of Philadelphia chromosome-negative myeloproliferative neoplasm.
Hu AY; Zhou T
Br J Haematol; 2019 Jan; 184(1):8. PubMed ID: 30407632
[No Abstract] [Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles.
Lyapichev KA; Sukswai N; Konoplev S; Khoury JD
Ann Hematol; 2019 Sep; 98(9):2221-2222. PubMed ID: 30955062
[No Abstract] [Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
13. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm.
Fernandes F; Barreira R; Cortez J; Silveira M; Bain BJ
Am J Hematol; 2018 Nov; 93(11):1431-1432. PubMed ID: 30020546
[No Abstract] [Full Text] [Related]
14. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Sun J; Yang M; Wang L; Jin J
Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
[TBL] [Abstract][Full Text] [Related]
15. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
Mizia-Malarz A; Sobol-Milejska G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
17. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
Kurt H; Khoury JD; Medeiros LJ; Huh YO
Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
[No Abstract] [Full Text] [Related]
19. Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.
Bétrian S; Guenounou S; Luquet I; Demur C; Huynh A; Ysebaert L; Recher C; Huguet F
Hematol Oncol; 2017 Jun; 35(2):252-255. PubMed ID: 28620927
[TBL] [Abstract][Full Text] [Related]
20. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Ceribelli M; Hou ZE; Kelly PN; Huang DW; Wright G; Ganapathi K; Evbuomwan MO; Pittaluga S; Shaffer AL; Marcucci G; Forman SJ; Xiao W; Guha R; Zhang X; Ferrer M; Chaperot L; Plumas J; Jaffe ES; Thomas CJ; Reizis B; Staudt LM
Cancer Cell; 2016 Nov; 30(5):764-778. PubMed ID: 27846392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
